Nov 14, 2016 12:01 pm UTC| Business
PLYMOUTH MEETING, Pa., Nov. 14, 2016 -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO), today announced an interim data analysis showing that its INO-3112 cancer immunotherapy product generated antigen-specific CD8+ killer T...
Nov 14, 2016 12:01 pm UTC| Business
PLYMOUTH MEETING, Pa., Nov. 14, 2016 -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO), today announced an interim data analysis showing that its INO-3112 cancer immunotherapy product generated antigen-specific CD8+ killer T...
Nov 14, 2016 12:01 pm UTC| Business
NEW YORK, Nov. 14, 2016 -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL) today reported encouraging preclinical efficacy for the treatment of neuropathic pain and visceral pain with their novel...
Nov 14, 2016 12:01 pm UTC| Business
NEW YORK, Nov. 14, 2016 -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL) today reported encouraging preclinical efficacy for the treatment of neuropathic pain and visceral pain with their novel...
Curis Announces Appointment of Lori A. Kunkel, M.D. to Board of Directors
Nov 14, 2016 12:01 pm UTC| Business
LEXINGTON, Mass., Nov. 14, 2016 -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers,...
Curis Announces Appointment of Lori A. Kunkel, M.D. to Board of Directors
Nov 14, 2016 12:01 pm UTC| Business
LEXINGTON, Mass., Nov. 14, 2016 -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers,...
StoneMor Partners L.P. Issues Update on Sales Team Development
Nov 14, 2016 12:01 pm UTC| Business
TREVOSE, Pa., Nov. 14, 2016 -- StoneMor Partners L.P. (NYSE:STON) (“StoneMor” or the “Partnership”) today provided additional data on the ongoing restructuring of its sales force. Larry Miller, StoneMor President and...